Status:
COMPLETED
Plasma Hepcidin Response to Differently Dosed Iron Supplements
Lead Sponsor:
Pierre-Alexandre Krayenbuehl
Conditions:
Iron Deficiency (Without Anemia)
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The study participants will take 3 different doses of iron supplements at 8 am, on 3 different days. By taking blood samples in the morning and afternoon, the investigators will determine the effects ...
Detailed Description
15 healthy young women with non-anemic iron deficiency will participate in the study. On 4 different days the investigators will take two blood samples (one in the morning at 8 am, before the iron int...
Eligibility Criteria
Inclusion
- Informed Consent as documented by signature
- Female gender
- Premenopausal
- Age \> 18 years
- Regular menstrual cycle
- BMI in normal range (18-25kg/m2)
- Serum-ferritin ≤30ng/ml
- No anemia
- No intake of dietary supplements
Exclusion
- Intake of dietary supplements
- Pregnancy
- Hypermenorrhea (\> 80ml blood loss, or more than 5 unties/tampons per day)
- Anemia
- Serum-ferritin \>30ng/ml
- BMI \<18 kg/m2 or \>25 kg/m2
- Chronic inflammatory disease
- Hypersensitivity to iron supplements
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04735848
Start Date
June 1 2021
End Date
August 31 2021
Last Update
October 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsspital Zürich
Zurich, Switzerland, 8091